Magellan
Commercial- Indications
- Orthopedic conditions
Company intelligence / Profile preview
Isto Biologics
Massachusetts, United Statesistobiologics.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Commercial
01
Overview
Isto Biologics offers commercial products for bone regeneration and cell-based therapies, including the market-leading Magellan® Autologous Platelet Separator and various bone graft products[1][3]
- Therapeutic areas
- OtherNeurologyRheumatology
- Modalities
- Autologous therapiesBone graftsCell-based therapiesPlatelet Rich PlasmaConcentrated Bone Marrow AspiratePlatelet Poor PlasmaAllografts
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Advanced Biologics (merged in 2023)
Beyond the preview
Go deeper on Isto Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Isto Biologics.